Search Results - "Blinkenberg, M."

Refine Results
  1. 1

    Anti-CD20 antibody therapy and risk of infection in patients with demyelinating diseases by Oksbjerg, N.R., Nielsen, S.D., Blinkenberg, M., Magyari, M., Sellebjerg, F.

    Published in Multiple sclerosis and related disorders (01-07-2021)
    “…•B-cell depletion therapy is widely used in patients with demyelinating diseases.•We analyzed risk of severe infections (requiring hospitalization) and herpes…”
    Get full text
    Journal Article
  2. 2

    Increased socioeconomic burden in patients with primary progressive multiple sclerosis: A Danish nationwide population-based study by Blinkenberg, M., Kjellberg, J., Ibsen, R., Magyari, M.

    Published in Multiple sclerosis and related disorders (01-11-2020)
    “…•Nation-wide study of societal costs in different forms of multiple sclerosis.•Primary progressive multiple sclerosis has the highest socioeconomic…”
    Get full text
    Journal Article
  3. 3

    Spinal cord atrophy in anterior‐posterior direction reflects impairment in multiple sclerosis by Lundell, H., Svolgaard, O., Dogonowski, A.‐M., Romme Christensen, J., Selleberg, F., Soelberg Sørensen, P., Blinkenberg, M., Siebner, H. R., Garde, E.

    Published in Acta neurologica Scandinavica (01-10-2017)
    “…Objective To investigate how atrophy is distributed over the cross section of the upper cervical spinal cord and how this relates to functional impairment in…”
    Get full text
    Journal Article
  4. 4

    Resting-state connectivity of pre-motor cortex reflects disability in multiple sclerosis by Dogonowski, A.-M., Siebner, H. R., Soelberg Sørensen, P., Paulson, O. B., Dyrby, T. B., Blinkenberg, M., Madsen, K. H.

    Published in Acta neurologica Scandinavica (01-11-2013)
    “…Objective To characterize the relationship between motor resting‐state connectivity of the dorsal pre‐motor cortex (PMd) and clinical disability in patients…”
    Get full text
    Journal Article
  5. 5

    Chronic cerebrospinal venous insufficiency and venous stenoses in multiple sclerosis by Blinkenberg, M., Åkeson, P., Sillesen, H., Lövgaard, S., Sellebjerg, F., Paulson, O. B., Siebner, H. R., Sørensen, P. S.

    Published in Acta neurologica Scandinavica (01-12-2012)
    “…Objectives The traditional view that multiple sclerosis (MS) is an autoimmune disease has recently been challenged by the claim that MS is caused by chronic…”
    Get full text
    Journal Article
  6. 6

    Regional Differences in the CBF and BOLD Responses to Hypercapnia: A Combined PET and fMRI Study by Rostrup, E., Law, I., Blinkenberg, M., Larsson, H.B.W., Born, A.P., Holm, S., Paulson, O.B.

    Published in NeuroImage (Orlando, Fla.) (01-02-2000)
    “…Previous fMRI studies of the cerebrovascular response to hypercapnia have shown signal change in cerebral gray matter, but not in white matter. Therefore, the…”
    Get full text
    Journal Article
  7. 7

    Intravenous immunoglobulin G reduces MRI activity in relapsing multiple sclerosis by SORENSEN, P. S, WANSCHER, B, JENSEN, C. V, SCHREIBER, K, BLINKENBERG, M, RAVNBORG, M, KIRSMEIER, H, LARSEN, V. A, LEE, M. L

    Published in Neurology (01-05-1998)
    “…We wanted to assess whether intravenous immunoglobulin G (IVIG) decreases disease activity on MRI in relapsing MS. Previous trials of IVIG in…”
    Get full text
    Journal Article
  8. 8

    Cortical cerebral metabolism correlates with MRI lesion load and cognitive dysfunction in MS by BLINKENBERG, M, RUNE, K, JENSEN, C. V, RAVNBORG, M, KYLLINGSBAEK, S, HOLM, S, PAULSON, O. B, SØRENSEN, P. S

    Published in Neurology (08-02-2000)
    “…To study the association between the cortical cerebral metabolic rate of glucose (CMRglc), MRI T2-weighted total lesion area (TLA), cognitive dysfunction, and…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Responsiveness of the Multiple Sclerosis Impairment Scale in comparison with the Expanded Disability Status Scale by Ravnborg, M, Blinkenberg, M, Sellebjerg, F, Ballegaard, M, Larsen, S Helweg, Sørensen, P Soelberg

    Published in Multiple sclerosis (01-02-2005)
    “…The Multiple Sclerosis Impairment Scale (MSIS) is a measure of accumulated deficits assessed by means of a standard neurological examination. We compared the…”
    Get full text
    Journal Article
  11. 11

    Apoliprotein E and multiple sclerosis: impact of the epsilon-4 allele on susceptibility, clinical type and progression rate by Høgh, P., Oturai, A., Schreiber, K., Blinkenberg, M., Jørgensen, O.S., Ryder, L., Paulson, O.B., Sørensen, P.S., Knudsen, G.M.

    Published in Multiple sclerosis (01-04-2000)
    “…The purpose of this study was to investigate the relation between APOE genotype and Multiple Sclerosis (MS) in a genetically homogeneous population. We…”
    Get full text
    Journal Article
  12. 12

    A longitudinal study of cerebral glucose metabolism, MRI, and disability in patients with MS by BLINKENBERG, M, JENSEN, C. V, HOLM, S, PAULSON, O. B, SØRENSEN, P. S

    Published in Neurology (13-07-1999)
    “…To study the time-related changes in cerebral metabolic rate of glucose (CMRglc) in MS patients and to correlate these with changes in MRI lesion load and…”
    Get full text
    Journal Article
  13. 13

    Correlations of brain MRI parameters to disability in multiple sclerosis by Schreiber, K., Sørensen, P. S., Koch-Henriksen, N., Wagner, A., Blinkenberg, M., Svarer, C., Petersen, H. C.

    Published in Acta neurologica Scandinavica (01-07-2001)
    “…Objectives– The objective was to correlate magnetic resonance imaging (MRI) T2‐weighted lesion load and measures of white matter atrophy in the brain to…”
    Get full text
    Journal Article
  14. 14

    A prospective PET study of patients with glioblastoma multiforme by Andersen, P. B., Blinkenberg, M., Lassen, U., Kosteljanetz, M., Wagner, A., Poulsen, H. S., Sørensen, P. S., Paulson, O. B.

    Published in Acta neurologica Scandinavica (01-06-2006)
    “…Objective –  To study the post‐surgical metabolic and structural cerebral changes in patients with glioblastoma multiforme (GBM). Materials and methods –  We…”
    Get full text
    Journal Article
  15. 15

    A double-blind, cross-over trial of intravenous immunoglobulin G in multiple sclerosis: preliminary results by Sørensen, P S, Wanscher, B, Schreiber, K, Blinkenberg, M, Jensen, C V, Ravnborg, M

    Published in Multiple sclerosis (01-04-1997)
    “…We enrolled 25 patients with relapsing-remitting or relapsing progressive multiple sclerosis (MS) in a randomized placebo-controlled double-blind study of…”
    Get more information
    Journal Article
  16. 16
  17. 17

    Cerebral metabolism in a case of multiple sclerosis with acute mental disorder by Blinkenberg, M, Rune, K, Jønsson, A, Holm, S, Jensen, C V, Paulson, O B, Sørensen, P S

    Published in Acta neurologica Scandinavica (01-11-1996)
    “…Acute mental disorder in early Multiple Sclerosis (MS) is rare and little is known about the structural and metabolic changes in this relation. We present an…”
    Get more information
    Journal Article
  18. 18

    No effect of pulsed magnetic stimulation on the blood-brain barrier in rats by Ravnborg, M, Knudsen, G M, Blinkenberg, M

    Published in Neuroscience (1990)
    “…The impact of transcranial pulsed magnetic stimulation on blood-brain barrier permeability was studied in rats. An integral uptake technique was used to asses…”
    Get more information
    Journal Article
  19. 19

    An immunohistochemical localization of neuropeptide Y (NPY) in its amidated form in human frontal cortex by Blinkenberg, M, Kruse-Larsen, C, Mikkelsen, J D

    Published in Peptides (New York, N.Y. : 1980) (01-01-1990)
    “…The distribution of neuropeptide Y (NPY)-immunoreactive neurons was studied in human frontal cerebral cortex from surgical biopsy specimens by…”
    Get more information
    Journal Article
  20. 20

    Tract-oriented statistical group comparison of diffusion in sheet-like white matter by Lyksborg, M., Dyrby, T. B., Sorensen, P. S., Blinkenberg, M., Siebner, H. R., Alexander, D., Larsen, R., Zhang, H.

    “…Identifying specific structures of the brain where pathology differs between groups of subjects may aid to develop imaging-based markers for disease diagnosis…”
    Get full text
    Conference Proceeding